Fioravanti M - Search Results

1

Cytidinediphosphocholine (CDP choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly.

Fioravanti M, Yanagi M. Fioravanti M, et al. Cochrane Database Syst Rev. 2004;(2):CD000269. doi: 10.1002/14651858.CD000269.pub2. Cochrane Database Syst Rev. 2004. PMID: 15106147 Updated. Review.

2

Cognitive deficits in schizophrenia: an updated metanalysis of the scientific evidence.

Fioravanti M, Bianchi V, Cinti ME. Fioravanti M, et al. BMC Psychiatry. 2012 Jun 20;12:64. doi: 10.1186/1471-244X-12-64. BMC Psychiatry. 2012. PMID: 22715980 Free PMC article.

3

Differential characteristics of the aging process and the vascular cognitive impairment in the organization of memory retrieval.

Di Cesare F, D'Ilario D, Fioravanti M. Di Cesare F, et al. Among authors: fioravanti m. J Neurol Sci. 2012 Nov 15;322(1-2):148-51. doi: 10.1016/j.jns.2012.07.042. Epub 2012 Aug 4. J Neurol Sci. 2012. PMID: 22868092

4

Differences between the aging process and the chronic cerebrovascular impairment of memory functioning: the emotional and cognitive interaction.

Fioravanti M. Fioravanti M. Rev Neurosci. 2012;23(5-6):691-6. doi: 10.1515/revneuro-2012-0059. Rev Neurosci. 2012. PMID: 23001313 Review.

5

Citicoline (Cognizin) in the treatment of cognitive impairment.

Fioravanti M, Buckley AE. Fioravanti M, et al. Clin Interv Aging. 2006;1(3):247-51. doi: 10.2147/ciia.2006.1.3.247. Clin Interv Aging. 2006. PMID: 18046877 Free PMC article. Review.

6

A meta-analysis of cognitive deficits in adults with a diagnosis of schizophrenia.

Fioravanti M, Carlone O, Vitale B, Cinti ME, Clare L. Fioravanti M, et al. Neuropsychol Rev. 2005 Jun;15(2):73-95. doi: 10.1007/s11065-005-6254-9. Neuropsychol Rev. 2005. PMID: 16211467

7

History of symptomatic therapy in vascular dementia.

Fioravanti M. Fioravanti M. Int Psychogeriatr. 2003;15 Suppl 1:177-81. doi: 10.1017/S1041610203009165. Int Psychogeriatr. 2003. PMID: 16191237

8

Relationship between memory, attention, and depression in chronic cerebro-vascular patients.

Fioravanti M, Carbone G, Galli N, Piccirilli E, Pierucci P. Fioravanti M, et al. J Neurol Sci. 2007 Jun 15;257(1-2):155-9. doi: 10.1016/j.jns.2007.01.019. Epub 2007 Apr 11. J Neurol Sci. 2007. PMID: 17433367

9

CDP-choline in the treatment of chronic cerebrovasculopathies.

Piccoli F, Battistini N, Carbonin P, Currò Dossi B, Fiori L, La Bella V, Megna G, Salvioli G, Fioravanti M. Piccoli F, et al. Among authors: fioravanti m. Arch Gerontol Geriatr. 1994 May-Jun;18(3):161-8. doi: 10.1016/0167-4943(94)90010-8. Arch Gerontol Geriatr. 1994. PMID: 15374296 Clinical Trial.

10

Randomized double-blind study of flunarizine versus placebo in patients with chronic cerebrovascular disorders.

Agnoli A, Manna V, Martucci N, Fioravanti M, Ferromilone F, Cananzi A, D'Andrea G, De Rosa A, Vizioli R, Sinforiani E, et al. Agnoli A, et al. Among authors: fioravanti m. Int J Clin Pharmacol Res. 1988;8(3):189-97. Int J Clin Pharmacol Res. 1988. PMID: 3042644 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results